Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A_135503, 31003A_152829, 33IC30_166785/1, NCCR Kidney.CH, NCCR Transcure)
Article History
Received: 25 July 2018
Accepted: 8 November 2018
First Online: 20 November 2018
Compliance with ethical standards
:
: The authors declare no conflicts of interest. DF has served as a consultant for Otsuka Pharmaceuticals. DF has received unrestricted research funding from Novartis, Abbvie and Otsuka Pharmaceuticals.